Quality Assurance Issues in Conducting Multi-Institutional Advanced Technology Clinical Trials
- 1 May 2008
- journal article
- Published by Elsevier BV in International Journal of Radiation Oncology*Biology*Physics
- Vol. 71 (1), S66-S70
- https://doi.org/10.1016/j.ijrobp.2007.07.2393
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- 3-D Radiation Treatment Planning: A New EraFrontiers of radiation therapy and oncology, 2015
- 1011International Journal of Radiation Oncology*Biology*Physics, 2006
- SU-FF-T-267: Implementation of ATC Method 1 for Clinical Trials Data Review at the Quality Assurance Review CenterMedical Physics, 2006
- Toxicity after three-dimensional radiotherapy for prostate cancer on RTOG 9406 dose Level VInternational Journal of Radiation Oncology*Biology*Physics, 2005
- Credentialing of institutions for IMRT in clinical trialsInternational Journal of Radiation Oncology*Biology*Physics, 2004
- Current ICRU definitions of volumes: limitations and future directionsSeminars in Radiation Oncology, 2004
- Preliminary evaluation of low-grade toxicity with conformal radiation therapy for prostate cancer on RTOG 9406 dose levels I and IIInternational Journal of Radiation Oncology*Biology*Physics, 2003
- Flat-panel cone-beam computed tomography for image-guided radiation therapyInternational Journal of Radiation Oncology*Biology*Physics, 2002
- Improvement in dose escalation using the process of adaptive radiotherapy combined with three-dimensional conformal or intensity-modulated beams for prostate cancerInternational Journal of Radiation Oncology*Biology*Physics, 2001
- Dose calculations for external photon beams in radiotherapyPhysics in Medicine & Biology, 1999